Articles dans des revues avec comité de lecture (55)
46.
Van Antwerpen, P., Dufrasne, F., Lequeux, M., Zouaoui Boudjeltia, K., Lessgyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2007). Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. European journal of pharmacology, 570(1-3), 235-243. doi:10.1016/j.ejphar.2007.05.05749.
Dullin, A., Dufrasne, F., Gelbcke, M., & Gust, R. (2006). Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes. ChemMedChem, 1(6), 644-653. doi:10.1002/cmdc.20060003250.
Guntz, E., Dumont, H., Roussel, C., Gall, D., Dufrasne, F., Cuvelier, L., Blum, D., Schiffmann, S. N., & Sosnowski, M. (2005). Effects of remifentanil on N-methyl-D-aspartate receptor: an electrophysiologic study in rat spinal cord. Anesthesiology, 102(6), 1235-1241.52.
Dullin, A., Dufrasne, F., Gelbcke, M., & Gust, R. (2004). Enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: Synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines. Archiv der Pharmazie, 337(12), 654-667. doi:10.1002/ardp.20040062153.
Dullin, A., Dufrasne, F., Gelbcke, M., & Gust, R. (2004). Enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: Synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines. Archiv der Pharmazie, 337(12), 654-667. doi:10.1002/ardp.20040062155.
Dufrasne, F., Gelbcke, M., Schnurr, B., & Gust, R. (2002). Synthesis and antitumor activity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)propane]dichloroplatinum(II) complexes. Archiv der Pharmazie, 335(5), 229-239. doi:10.1002/1521-4184(200205)335:5<229::AID-ARDP229>3.0.CO;2-Q Communications publiées lors de congrès ou colloques nationaux et internationaux (2)
1.
Marloye, M., Berger, G., Ingels, A., Meyer, F., Gelbcke, M., Mathieu, V., & Dufrasne, F. (2017). Design and synthesis of novel ruthenium(ii) and osmium(ii) complexes with potential antitumor activity. In R. Frederick, L. Pochet, P. de Tullio, & F. Dufrasne (Eds.), 31ièmes Journées Franco-Belges de Pharmacochimie: Meeting Report: Vol. 10 (4 ed., pp. 9-10) Bâle: MDPI.